Search in:

Advanced search

Clinical Ophthalmology Volume 12, 2018 - Issue

Submit an article Journal homepage

Open access

151

Views

CrossRef citations to date

Altmetric

Original Research

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

Szilárd Kiss1 Department of Ophthalmology, Weill Cornell Medical College, New York, NY, USA, [email protected]Correspondence[email protected]

Pravin U Dugel2 Retinal Consultants of Arizona, Phoenix, AZ, USA;3 USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Arshad M Khanani4 Sierra Eye Associates, Reno, NV, USA

Michael S Broder5 Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA

Eunice Chang5 Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA

Gordon H Sun5 Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA

Adam Turpcu6 Genentech, Inc., South San Francisco, CA, USA

show all

Pages 1625-1635 | Published online: 30 Aug 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Genentech, IncLUCENTIS^® (ranibizumab injection) [package insert]2015 Available from: http://www.gene.com/download/pdf/lucentis_prescribing.pdfAccessed May 5, 2015
Google Scholar
Regeneron, IncEYLEA^® (aflibercept injection) [package insert]2015 Available from: https://www.regeneron.com/Eylea/eylea-fpi.pdfAccessed May 5, 2015
Google Scholar
SolomonSDLindsleyKVedulaSSKrzystolikMGHawkinsBSAnti-vascular endothelial growth factor for neovascular age-related macular degenerationCochrane Database Syst Rev20148CD005139
PubMed Web of Science ®Google Scholar
HahnPChungMMFlynnHWJrPostmarketing analysis of aflibercept-related sterile intraocular inflammationJAMA Ophthalmol2015133442142625590968
PubMed Web of Science ®Google Scholar
FiletaJBScottIUFlynnHWJrMeta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agentsOphthalmic Surg Lasers Imaging Retina201445214314924635156
PubMed Web of Science ®Google Scholar
VanderBeekBLBonaffiniSGMaLThe association between intravitreal steroids and post-injection endophthalmitis ratesOphthalmology2015122112311.e12315.e126281823
PubMed Web of Science ®Google Scholar
DossarpsDBronAMKoehrerPAho-GléléLSCreuzot-GarcherCFRCR net (FRenCh Retina specialists net)Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcomeAm J Ophthalmol2015160117.e125.e125892127
PubMed Web of Science ®Google Scholar
FineHFRothDBShahSPHaqueTWheatleyHMFrequency and characteristics of intraocular inflammation after aflibercept injectionRetina201535468168625394166
PubMed Web of Science ®Google Scholar
GoldbergRAShahCPWiegandTWHeierJSNoninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomesAm J Ophthalmol20141584733.e1737.e124983791
PubMed Web of Science ®Google Scholar
JohnsonDHollandsHHollandsSSharmaSIncidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort studyCan J Ophthalmol201045323924220436545
PubMed Web of Science ®Google Scholar
WickremasingheSSMichalovaKGilhotraJAcute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degenerationOphthalmology2008115111911191518672291
PubMed Web of Science ®Google Scholar
FineHFDespotidisGDPrennerJLOcular inflammation associated with antivascular endothelial growth factor treatmentCurr Opin Ophthalmol201526318418725822254
PubMed Web of Science ®Google Scholar
Centers for Disease Control and PreventionInternational Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Last update6182013 Available from: http://www.cdc.gov/nchs/icd/icd9cm.htmAccessed May 27, 2014
Google Scholar
FintakDRShahGKBlinderKJIncidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabRetina200828101395139918827737
PubMed Web of Science ®Google Scholar
VanderBeekBLBonaffiniSGMaLAssociation of compounded bevacizumab with postinjection endophthalmitisJAMA Ophthalmol2015133101159116426270251
PubMed Web of Science ®Google Scholar
WilliamsPDChongDFullerTCallananDNoninfectious vitritis after intravitreal injection of anti-VEGF agents: variations in rates and presentation by medicationRetina201636590991327115856
PubMed Web of Science ®Google Scholar
WangFYuSLiuKAcute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, ChinaOphthalmology2013120235536123084126
PubMed Web of Science ®Google Scholar
YamashiroKTsujikawaAMiyamotoKSterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batchRetina201030348549019952993
PubMed Web of Science ®Google Scholar
EntezariMRamezaniAAhmadiehHGhasemiHBatch-related sterile endophthalmitis following intravitreal injection of bevacizumabIndian J Ophthalmol201462446847123619494
PubMed Web of Science ®Google Scholar
FieldenMNelsonBKheraniAAcute intraocular inflammation following intravitreal injection of bevacizumab – a large cluster of casesActa Ophthalmol2011898e664e66521159147
PubMed Web of Science ®Google Scholar
AgrawalSJoshiMChristoforidisJBVitreous inflammation associated with intravitreal anti-VEGF pharmacotherapyMediators Inflamm2013201394340924307762
PubMed Web of Science ®Google Scholar
KorenEZuckermanLAMire-SluisARImmune responses to therapeutic proteins in humans – clinical significance, assessment and predictionCurr Pharm Biotechnol20023434936012463417
PubMedGoogle Scholar
Endophthalmitis Vitrectomy Study GroupResults of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitisArch Ophthalmol199511312147914967487614
PubMedGoogle Scholar
GowerEWKeayLJStareDECharacteristics of endophthalmitis after cataract surgery in the United States Medicare populationOphthalmology201512281625163226045364
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date